Should donors be allowed to give broad consent to future biobank research?
(2006) In The Lancet Oncology 7(3). p.266-269- Abstract
- Large international biobank studies can make substantial contributions to scientific research by validation of the biological importance of previous research and by identification of previously unknown causes of disease. However, regulations for patient consent that are too strict and discrepancies in national policies on informed consent might hinder progress. Therefore, establishment of common ground for ethical review of biobank research is essential. in this essay, broad consent is defined on a scale between strictly specified (eg, for a specific study) and blanket consent (ie, with no restrictions regarding the purpose of the research). Future research includes that which might not be planned or even conceptualised when consent is... (More)
- Large international biobank studies can make substantial contributions to scientific research by validation of the biological importance of previous research and by identification of previously unknown causes of disease. However, regulations for patient consent that are too strict and discrepancies in national policies on informed consent might hinder progress. Therefore, establishment of common ground for ethical review of biobank research is essential. in this essay, broad consent is defined on a scale between strictly specified (eg, for a specific study) and blanket consent (ie, with no restrictions regarding the purpose of the research). Future research includes that which might not be planned or even conceptualised when consent is obtained. In conclusion, broad consent and consent for future research are valid ethically and should be recommended for biobank research provided that: personal information related to research is handled safely; donors of biological samples are granted the right to withdraw consent; and new research studies or changes to the legal or ethical authority of a biobank are approved by an ethics-review board. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/415072
- author
- Hansson, MG ; Dillner, Joakim LU ; Bartrarn, CR ; Carlson, Joyce LU and Helgesson, G
- organization
- publishing date
- 2006
- type
- Contribution to journal
- publication status
- published
- subject
- in
- The Lancet Oncology
- volume
- 7
- issue
- 3
- pages
- 266 - 269
- publisher
- Elsevier
- external identifiers
-
- wos:000236342900031
- pmid:16510336
- scopus:33344475590
- ISSN
- 1474-5488
- DOI
- 10.1016/S1470-2045(06)70618-0
- language
- English
- LU publication?
- yes
- id
- c06b09b6-3e9e-45fa-a452-7f7dba3a45af (old id 415072)
- date added to LUP
- 2016-04-01 12:05:45
- date last changed
- 2022-05-14 17:33:27
@article{c06b09b6-3e9e-45fa-a452-7f7dba3a45af,
abstract = {{Large international biobank studies can make substantial contributions to scientific research by validation of the biological importance of previous research and by identification of previously unknown causes of disease. However, regulations for patient consent that are too strict and discrepancies in national policies on informed consent might hinder progress. Therefore, establishment of common ground for ethical review of biobank research is essential. in this essay, broad consent is defined on a scale between strictly specified (eg, for a specific study) and blanket consent (ie, with no restrictions regarding the purpose of the research). Future research includes that which might not be planned or even conceptualised when consent is obtained. In conclusion, broad consent and consent for future research are valid ethically and should be recommended for biobank research provided that: personal information related to research is handled safely; donors of biological samples are granted the right to withdraw consent; and new research studies or changes to the legal or ethical authority of a biobank are approved by an ethics-review board.}},
author = {{Hansson, MG and Dillner, Joakim and Bartrarn, CR and Carlson, Joyce and Helgesson, G}},
issn = {{1474-5488}},
language = {{eng}},
number = {{3}},
pages = {{266--269}},
publisher = {{Elsevier}},
series = {{The Lancet Oncology}},
title = {{Should donors be allowed to give broad consent to future biobank research?}},
url = {{http://dx.doi.org/10.1016/S1470-2045(06)70618-0}},
doi = {{10.1016/S1470-2045(06)70618-0}},
volume = {{7}},
year = {{2006}},
}